| Elizabeth A Sherman, APRN, PMHNP-BC | |
|
400 Massasoit Ave Ste 305, East Providence, RI 02914-2012 | |
| (401) 294-0451 | |
| (401) 294-0461 |
| Full Name | Elizabeth A Sherman |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 400 Massasoit Ave Ste 305, East Providence, Rhode Island |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730595893 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364S00000X | Clinical Nurse Specialist | APRN00972 (Rhode Island) | Secondary |
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | APRN03127 (Rhode Island) | Primary |
| Entity Name | The Providence Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104847946 PECOS PAC ID: 9739080292 Enrollment ID: O20040116000840 |
News Archive
Mevion Medical Systems, the leader in compact proton therapy, is announcing that University Hospitals in Cleveland used the industry-leading MEVION S250 proton therapy system to treat its first patient, a 24-year-old woman with, rhabdomyosarcoma, a rare form of sarcoma. The proton therapy treatment made history by being the first in the state of Ohio.
The biggest killer of women over the age of 50 is heart disease. By age 65 women have the same heart attack or stroke risk as men and a greater risk of dying from either. To help better predict heart attack risk in these women, Atherotech Diagnostics Lab has developed a new and better way to test for heart disease risk. The new test will soon be available exclusively through Atherotech Diagnostics Lab.
Zimmer Holdings, Inc. announced today the debut of a new mobile app designed to serve as a feature-rich resource for patients of its Gel-One Hyaluronate product.
Much like two children in the back seat of a car, it can be challenging to get two catalysts to cooperate for the greater good. Now Northwestern University chemists have gotten two catalysts to work together on the same task - something easily done by nature but a difficult thing to do in the laboratory.The findings, published by the journal Nature Chemistry, will allow medicinal chemists to invent new reactions and produce valuable bioactive compounds faster with less impact on the environment.
Through a groundbreaking new award from New York City Economic Development Corporation (NYCEDC), Columbia University – through its Mailman School of Public Health – and a consortium of academic, community, government, and corporate partners will launch and operate New York City's first Pandemic Response Institute (PRI).
› Verified 8 days ago
| Entity Name | Ricbt, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780776476 PECOS PAC ID: 7517854995 Enrollment ID: O20040301000979 |
News Archive
Mevion Medical Systems, the leader in compact proton therapy, is announcing that University Hospitals in Cleveland used the industry-leading MEVION S250 proton therapy system to treat its first patient, a 24-year-old woman with, rhabdomyosarcoma, a rare form of sarcoma. The proton therapy treatment made history by being the first in the state of Ohio.
The biggest killer of women over the age of 50 is heart disease. By age 65 women have the same heart attack or stroke risk as men and a greater risk of dying from either. To help better predict heart attack risk in these women, Atherotech Diagnostics Lab has developed a new and better way to test for heart disease risk. The new test will soon be available exclusively through Atherotech Diagnostics Lab.
Zimmer Holdings, Inc. announced today the debut of a new mobile app designed to serve as a feature-rich resource for patients of its Gel-One Hyaluronate product.
Much like two children in the back seat of a car, it can be challenging to get two catalysts to cooperate for the greater good. Now Northwestern University chemists have gotten two catalysts to work together on the same task - something easily done by nature but a difficult thing to do in the laboratory.The findings, published by the journal Nature Chemistry, will allow medicinal chemists to invent new reactions and produce valuable bioactive compounds faster with less impact on the environment.
Through a groundbreaking new award from New York City Economic Development Corporation (NYCEDC), Columbia University – through its Mailman School of Public Health – and a consortium of academic, community, government, and corporate partners will launch and operate New York City's first Pandemic Response Institute (PRI).
› Verified 8 days ago
| Entity Name | Northwest Community Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801951397 PECOS PAC ID: 1355250663 Enrollment ID: O20050308000422 |
News Archive
Mevion Medical Systems, the leader in compact proton therapy, is announcing that University Hospitals in Cleveland used the industry-leading MEVION S250 proton therapy system to treat its first patient, a 24-year-old woman with, rhabdomyosarcoma, a rare form of sarcoma. The proton therapy treatment made history by being the first in the state of Ohio.
The biggest killer of women over the age of 50 is heart disease. By age 65 women have the same heart attack or stroke risk as men and a greater risk of dying from either. To help better predict heart attack risk in these women, Atherotech Diagnostics Lab has developed a new and better way to test for heart disease risk. The new test will soon be available exclusively through Atherotech Diagnostics Lab.
Zimmer Holdings, Inc. announced today the debut of a new mobile app designed to serve as a feature-rich resource for patients of its Gel-One Hyaluronate product.
Much like two children in the back seat of a car, it can be challenging to get two catalysts to cooperate for the greater good. Now Northwestern University chemists have gotten two catalysts to work together on the same task - something easily done by nature but a difficult thing to do in the laboratory.The findings, published by the journal Nature Chemistry, will allow medicinal chemists to invent new reactions and produce valuable bioactive compounds faster with less impact on the environment.
Through a groundbreaking new award from New York City Economic Development Corporation (NYCEDC), Columbia University – through its Mailman School of Public Health – and a consortium of academic, community, government, and corporate partners will launch and operate New York City's first Pandemic Response Institute (PRI).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth A Sherman, APRN, PMHNP-BC 1130 Ten Rod Rd Ste E305, North Kingstown, RI 02852-4176 Ph: (401) 294-0451 | Elizabeth A Sherman, APRN, PMHNP-BC 400 Massasoit Ave Ste 305, East Providence, RI 02914-2012 Ph: (401) 294-0451 |
News Archive
Mevion Medical Systems, the leader in compact proton therapy, is announcing that University Hospitals in Cleveland used the industry-leading MEVION S250 proton therapy system to treat its first patient, a 24-year-old woman with, rhabdomyosarcoma, a rare form of sarcoma. The proton therapy treatment made history by being the first in the state of Ohio.
The biggest killer of women over the age of 50 is heart disease. By age 65 women have the same heart attack or stroke risk as men and a greater risk of dying from either. To help better predict heart attack risk in these women, Atherotech Diagnostics Lab has developed a new and better way to test for heart disease risk. The new test will soon be available exclusively through Atherotech Diagnostics Lab.
Zimmer Holdings, Inc. announced today the debut of a new mobile app designed to serve as a feature-rich resource for patients of its Gel-One Hyaluronate product.
Much like two children in the back seat of a car, it can be challenging to get two catalysts to cooperate for the greater good. Now Northwestern University chemists have gotten two catalysts to work together on the same task - something easily done by nature but a difficult thing to do in the laboratory.The findings, published by the journal Nature Chemistry, will allow medicinal chemists to invent new reactions and produce valuable bioactive compounds faster with less impact on the environment.
Through a groundbreaking new award from New York City Economic Development Corporation (NYCEDC), Columbia University – through its Mailman School of Public Health – and a consortium of academic, community, government, and corporate partners will launch and operate New York City's first Pandemic Response Institute (PRI).
› Verified 8 days ago
Michelle L Fox, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 900 Warren Ave Ste 401, East Providence, RI 02914 Phone: 401-330-2480 | |
Regina B Monteiro, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 950 Warren Ave Fl 2, East Providence, RI 02914 Phone: 401-606-1006 | |
Danielle Barry, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Kettle Point Ave, East Providence, RI 02914 Phone: 401-457-1500 Fax: 401-349-4373 | |
Taylor Selke, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 400 Massasoit Ave Ste 305, East Providence, RI 02914 Phone: 401-294-0451 | |
Ann Garris, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 450 Veterans Memorial Pkwy, Bldg. 4, East Providence, RI 02914 Phone: 401-435-3400 Fax: 401-435-3586 | |
Cara Beth Cavazza, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1 Office Pkwy, East Providence, RI 02914 Phone: 401-435-3325 | |
Kimberly Jill Gallucci, MSN, APRN, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 450 Veterans Memorial Pkwy Ste 7a, East Providence, RI 02914 Phone: 401-499-8187 |